ProCE Banner Activity

The Nuances of NTM Lung Disease Diagnosis

Clinical Thought

Many nuances influence how NTM lung disease presents, which can make it challenging to correctly diagnose. Here’s how I approach the 3 main “pillars” of NTM lung disease diagnosis.

Released: November 01, 2023

Share

Faculty

Pamela J. McShane

Pamela J. McShane, MD

Professor of Medicine
Division of Pulmonary and Critical Care Medicine
The University of Texas Health
Science Center at Tyler
Tyler, Texas

Provided by

Provided by Clinical Care Options, LLC, produced in partnership with NTM Info & Research (NTMir).

ProCE Banner

Supporters

Supported by an educational grant from Insmed Incorporated.

Insmed Incorporated

Partners

NTMIR

ProCE Banner

Disclosure

Primary Author

Pamela J. McShane, MD

Professor of Medicine
Division of Pulmonary and Critical Care Medicine
The University of Texas Health
Science Center at Tyler
Tyler, Texas

Pamela J. McShane, MD: researcher: AN2 Therapeutics, Armata, Boehringher Ingelheim, Electromed, Insmed, MannKind, Paratek, Renovian, Spero; data monitoring committee: GREAT-2; advisor: Boehringer Ingelheim, Insmed, Spero.